Sanofi partners with HHS to work on COVID-19 vaccine
19-02-2020
J&J, HHS sign expanded deal to find COVID-19 vaccine
14-02-2020
CHRISTOPHER E ZIMMER / Shutterstock.com
The US Department of Health and Human Services (HHS) will reveal more information regarding its licensing of IP to private companies for drug development, it has confirmed in a letter to a congressional watchdog.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Department of Health and Human Services,Government Accountability Office, US Food and Drug Administration, patents, IP, licence, licensing
